Natural killer receptor repertoires in transplantation

European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics
D C Jones, N T Young

Abstract

Natural killer (NK) lymphocytes are potent effector cells that are controlled by the expression of a variety of cell surface receptors with either inhibitory or activating functions. The genetic and functional diversity of this receptor repertoire and the role of HLA class I molecules as a major group of NK receptor ligands create an innate alloreactive capacity in this cell type. Both animal models and in vitro studies have implicated NK cells as contributors to the pathology of clinical transplantation. However, recent clinical studies have indicated the potential benefit of exploiting NK cell alloreactivity in mismatched haematopoietic stem cell transplantation. Further investigations of NK cell alloreactivity will undoubtedly reveal additional applications of this fundamental cell type in clinical transplantation.

References

Aug 1, 1995·The Journal of Experimental Medicine·W M Yokoyama
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·M C MingariL Moretta
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·A CambiaggiE Vivier
Jan 16, 1998·Immunity·M UhrbergP Parham
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·M C MingariL Moretta
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·O AyalonJ R Bender
Mar 5, 1998·Nature·V M BraudA J McMichael
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·N LeeD E Geraghty
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·M J WilsonJ Trowsdale
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·N T YoungP Parham
Mar 13, 2001·Annual Review of Immunology·D H RauletC W McMahon
Apr 5, 2001·Trends in Immunology·R BartenM J Wilson
Jun 29, 2001·Trends in Immunology·H A Stephens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.